Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Drug Manufacturers - Specialty & Generic
US, Canonsburg [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 10.83 | 28.69 | 25.88 | |
| Graham Fair Price | -61.70 | 5.99 | 15.65 | |
| PEG | 2010.68 | -0.27 | 0.01 | |
| Price/Book | 12.28 | 0.71 | 0.64 | |
| Price/Cash Flow | -45.76 | 25.31 | 46.67 | |
| Prices/Earnings | 638.04 | 31.32 | -4.24 | |
| Price/Sales | 14.83 | 3.90 | 3.40 | |
| Price/FCF | -45.76 | 25.31 | 46.67 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -1.28 | 0.42 | 0.42 | |
| Operating Margin | -19.77 | 0.11 | 0.14 | |
| ROA | -85.02 | < 0.005 | -0.02 | |
| ROE | -0.04 | < 0.005 | -84.79 | |
| ROIC | 0.01 | < 0.005 | -51.55 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | < 0.005 | < 0.005 | -3566.79 | |
| Dividends QOQ | < 0.005 | < 0.005 | 2092.86 | |
| EBIT QOQ | 0.17 | -0.23 | 35.20 | |
| EPS QOQ | -3.29 | 1.15 | -65.03 | |
| FCF QOQ | -0.62 | 1.02 | 65.35 | |
| Revenue QOQ | -0.03 | -0.04 | -47.23 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 141.05 | 161.05 | 14.18 | |
| Days Sales Outstanding (DSO) | 95.09 | 97.04 | 2.05 | |
| Inventory Turnover | 0.64 | 0.56 | -12.42 | |
| Debt/Capitalization | 0.47 | 0.47 | 0.74 | |
| Quick Ratio | 0.66 | 0.65 | -1.17 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 17.05 | 16.75 | -1.81 | |
| Cash | 0.90 | 0.93 | 2.90 | |
| Capex | -0.17 | -0.04 | 74.61 | |
| Free Cash Flow | 0.23 | 0.47 | 103.27 | |
| Revenue | 3.19 | 3.06 | -3.99 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Positive
Fundamentals
Financial Health
06 - Financial Health ·
Weak